Alter-Pharma

Alter-Pharma is a Belgian pharmaceutical group focused on the development, manufacturing, and distribution of high-quality, affordable medicines, particularly niche generics and value-added medicines. The company specializes in complex pharmaceutical formulations and injectable products, aiming to improve patient access to essential treatments across various therapeutic areas. Headquartered in Brussels, Alter-Pharma operates through a vertically integrated model that includes in-house R&D and a robust distribution network. Their portfolio includes a range of hospital-based and retail products, such as paracetamol and ibuprofen in intravenous forms. The group is backed by private equity investment and maintains a strong presence in the European market while expanding globally.